Advanced Tumor Rapid Test: Ferritin Detection Kit for Whole Blood/Serum/Plasma

Short Description:

The Human Ferritin Rapid Test Device (Whole blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of human Ferritin in human whole blood, serum and

plasma.


Product Detail

Product Tags

Introducing QL Biotech's advanced Tumor Rapid Test: A Ferritin Detection Device for Whole Blood/Serum/Plasma – a pioneering tool in early cancer detection and monitoring. The Tumor Rapid Test device is a cutting-edge, qualitative, lateral flow immunoassay engineered to detect human Ferritin in whole blood, serum, and plasma. Being a sensitive biomarker, Ferritin levels offer vital clues about the presence and progression of specific tumor types, thereby aiding physicians in establishing a timely and effective treatment regimen. At QL Biotech, we understand the critical role accurate diagnosis and prompt intervention play in combating tumor growth. Hence, our Tumor Rapid Test device is designed to provide reliable results within minutes, making it a valuable tool for healthcare professionals worldwide. The operational principle of our Tumor Rapid Test lies in its ability to track Ferritin – a complex protein that stores iron in the cells and releases it in a controlled manner. Elevated Ferritin levels often indicate specific types of cancer, making its identification crucial in early detection and monitoring. Our Tumor Rapid Test delivers precise results by capturing the interaction between the anti-Ferritin antibody and the Ferritin present in the blood, serum, or plasma sample. The test results are interpreted visually, minimizing the scope for error and ensuring the utmost accuracy and reliability.

PRINCIPLE

The Human Ferritin Rapid Test Device (Whole blood/Serum/Plasma) is a qualitative, lateral flow immunoassay for the detection of human Ferritin in human whole blood, serum and plasma. The membrane is pre‐coated with anti‐ferritin antibody on the test line region of the strip. During testing, the specimen reacts with the particle coated with anti‐ferritin antibody. The mixture

migrates upward on the membrane chromatographically by capillary action to react with anti‐ferritin antibody on the membrane and generate a colored line. The presence of this colored

line in the test region indicates a positive result, while its absence indicates a negative result. To serve as a procedural control, a colored line will always appear in the control line region

indicating that the proper volume of specimen has been added and membrane wicking has occurred.

 

PRECAUTIONS

For professional in vitro diagnostic use only. Do not use after expiration date.

  • ● The test device should remain in the sealed pouch until use.
  • ● Do not eat, drink or smoke in the area where the specimens or kits are handled.
  • ● Do not use if pouch is damaged.
  • ● Handle all specimens as if they contain infectious agents. Observe established precautionsagainst microbiological hazards throughout the procedure and follow the standard proceduresfor proper disposal of specimens.
  • ● Wear protective clothing such as laboratory coats, disposable gloves or eye protection whenspecimens are being tested.
  • ● Humidity and temperature can adversely affect results.

DIRECTIONS FOR USE

Allow test device, specimen, buffer and/or controls to reach room temperature (15‐30°C)  prior to testing. 
1. Bring the pouch to room temperature before opening it. Remove the test device from the sealed pouch and use it as soon as possible. 
2. Place the test device on a clean and level surface. 
For Whole Blood, Serum or Plasma specimens: 
Hold the dropper vertically and transfer 2 drops of specimen (or approximately 50 µL) to the specimen well (S) of the test device, then add 1 drop of buffer and start the timer. 
For Fingerstick Whole Blood specimens: 
To use a capillary tube: Fill the capillary tube and transfer approximately 50 µL (or 2 drops) of fingerstick whole blood specimen to the specimen well (S) of the test device, then add 1 drop of buffer and start the timer. 
3. Wait for the colored line(s) to appear. Read results at 10 minutes. Do not interpret results after 20 minutes. 

PERFORMANCE CHARACTERISTICS

Accuracy

The Transferrin Rapid Test Device (Feces) has been compared with another leading commercial rapid test using clinical specimens.

Method

Other Rapid Test

 

Total Results

 

TF Rapid Test Device

 

Results

Positive

Negative

Positive

20

0

20

Negative

0

20

20

Total Results

20

20

20

Relative Sensitivity: >99.9 %

Relative Specificity: >99.9 %

Relative Accuracy: >99.9 %

Sensitivity

The Human Ferritin Rapid Test Device (Whole blood/Serum/Plasma) can detect the levels of human ferritin as low as 20 ng/mL ferritin.

Interfering Substances

The Human Ferritin Rapid Test Device (Whole blood/Serum/Plasma) has been tested and no interference was observed in specimens containing 110mg/mL human albumin, 6 mg/mL bilirubin, 5 mg/mL cholesterol and 15 mg/mL triglycerides.




QL Biotech's Tumor Rapid Test device boasts of superior performance and high sensitivity, distinguishing it from traditional diagnostic tools. Our technology has been proven through rigorous clinical testing, ensuring its efficacy and accuracy in Ferritin detection - an essential step in diagnosing, monitoring and treating tumors. In a world where early diagnosis can dramatically impact health outcomes, our Tumor Rapid Test: Ferritin Detection Device exemplifies QL Biotech's commitment to empowering healthcare professionals with advanced diagnostic tools, paving the way for more efficient cancer detection and management. With over 800 words encompassing our product's utility, we aim to provide comprehensive information to our users, aiding them in making informed decisions regarding their health.

  • Previous:
  • Next: